Background: obesity is associated with increased mortality in the general population but, paradoxically, with decreased mortality in persons with diabetes. Methods: Among 88,373 french women participating in the e3N-epiC study who were free of diabetes in 1990, we estimated the hazard ratios (Hrs) and 95% confidence intervals (Cis) of mortality for body mass index (BMi) levels by diabetes status. Results: During an average 16.7 years of follow-up, 2421 cases of diabetes were identified and 3750 deaths occurred. for overweight/ obese versus normal-weight women, the Hr of mortality was 1.42 (95% Ci = 1.32-1.53) in women without diabetes and 0.69 (0.40-1.18) in women with incident diabetes. As BMi increased, mortality among women without diabetes increased and that among women with diabetes decreased.
http://links.lww.com/eDe/A739; for age-adjusted characteristics by BMi group). overweight/obese women had higher diabetes incidence rates (56.0 per 10,000 person-years) than normal-weight women (7.9 per 10,000 person-years); mortality was also higher for overweight/obese women (38.3 per 10,000 person-years) than for normal-weight women (22.6 per 10,000 person-years). the adjusted Hr for overweight/obesity versus normal weight was 6.10 (95% confidence interval [Ci] = 5.60-6.64) for diabetes and 1.33 (1.23-1.43) for mortality (table 1) . results did not materially change after excluding women with cancer/cardiovascular disease at baseline and smokers. Mortality increased with BMi (eAppendix figure 2, http://links.lww.com/eDe/A739).
Among women without diabetes, mortality was higher in overweight/obese persons than in those of normal weight (38.8 vs. 22 .5 per 10,000 person-years). the Hr of mortality was 1.42 (95% Ci = 1.32-1.53) and did not change after exclusion of women with cancer or cardiovascular disease or after exclusion of women who were also smokers (table 2) . Mortality increased with BMi (figure 1). Conversely, among women with diabetes, mortality was lower in overweight/obese women than in those with normal weight (26.2 vs. 43.3 per 10,000 person-years). the Hr of mortality was 0.69 (0.40-1.18) (table 2) . After excluding women with cancer/cardiovascular disease and smokers, the Hr was 0.41 (0.18-0.92). Mortality decreased as BMi increased (figure 2). these findings illustrate the paradox via a direct comparison between women with and without diabetes from the same population.
in sensitivity analyses, we found similar estimates when we (1) used the BMi just before diabetes diagnosis (eAppendix table 3, http://links.lww.com/eDe/A739); (2) used BMi as a time-varying exposure; (3) repeated the analyses starting follow-up in 1993 (when dietary information was first available) and adjusted for coffee, fruits, and vegetables and processed red meat intake (eAppendix table 4, http://links.lww. com/eDe/A739); (4) replaced BMi with waist circumference and started the follow-up in 1994 (eAppendix table 5, http:// links.lww.com/eDe/A739); and (5) censored women after two missed questionnaires.
EXPLANATION OF THE PARADOX
Biological explanations for the paradox rely on potential benefits of obesity [12] [13] [14] or differences 2 (perhaps genetic) 15 between normal-weight and overweight/obese persons with diabetes that put those with normal weight at a higher mortality risk. However, there is an alternative explanation that does not require positing any benefits of elevated BMi 7 -selection bias because of conditioning on a variable affected by exposure. [7] [8] [9] An analysis restricted to persons with diabetes is conditioned on a variable (diabetes) that is affected by exposure (BMi), as well as by unmeasured risk factors for mortality such as lifestyle and genes. According to the simplified causal diagram in figure 3A , stratifying the analysis on diabetes (a collider) will generally induce an association between BMi and mortality through other common causes U, even if no association existed in the unstratified analysis. Similar causal diagrams have been proposed to explain the birth weight paradox 16 and some components of Simpson's paradox. 17 to see how the bias arises, first suppose that the only causes of diabetes are obesity and a genetic factor that, independently, increases the risk of mortality. in this oversimplified scenario, all persons with diabetes are either obese or have the genetic factor (or both), and all normal-weight persons with diabetes necessarily have the genetic factor that results in higher mortality. in other words, an inverse association between obesity and mortality-the paradox-is expected among persons with diabetes. this inverse association is also expected in the more realistic setting with multiple causes of diabetes other than obesity and the genetic factor (eg, lifestyle). in this case, normal-weight persons with diabetes are more likely to have other risk factors for mortality.
the above explanation can also accommodate the possibility that diabetes may be a collection of similar diseases with different etiologies and with different effects on mortality. Suppose that diabetes, type A is a disorder caused by high BMi; that diabetes, type B is a condition caused by other causes U; and that there are no shared causes of types A and B. Also suppose that diabetes-type B, but not type A-increases mortality. this scenario is depicted in figure 3B, which is an elaboration of figure 3A. Under this scenario, an analysis restricted to patients with diabetes, type A would not introduce selection bias (diabetes, type A is not a collider). However, because the type of diabetes is unknown in practice, any analysis restricted to those with diabetes (without specifying the type) will be conditioned on a collider, which may therefore introduce selection bias. the bias has a structure similar to that of the birth weight paradox, 16 some components of Simpson's paradox, 17 Berkson's fallacy, 18 adjustment for time-varying confounders affected by prior treatment, 6 and including prevalent users in drug safety studies. 19, 20 our analysis has several strengths that help rule out alternative explanations-other than conditioning on a colliderto the paradox. these strengths include measurement of BMi before the diagnosis of diabetes, long-term follow-up, use of incident cases of confirmed diabetes, no differential access to health care among participants, and a detailed assessment of lifestyle factors and clinical diagnoses. However, compared with other cohorts, 2 e3N participants are leaner, which limits our ability to study high levels of BMi.
PRACTICAL IMPLICATIONS OF THE PARADOX
if the paradox is indeed an example of selection bias, then the lower mortality risk in overweight person with diabetes should not be the basis for weight management recommendations to persons with diabetes. Similarly, the lower mortality in low-birth-weight babies of smokers (the birth weight paradox) 16 should not be the basis for recommending maternal smoking, and the lower risk of heart disease in prevalent users of estrogen plus progestin hormone therapy should not be the basis for recommending preventive hormone therapy. 21 the argument that conditioning on diabetes is necessary to estimate the effect of BMi in persons with diabetes and non-diabetes separately is invalid for the same reason that one cannot generally estimate the effects of a randomized treatment within levels of a post-randomization variable.
the implications of the obesity paradox are harder to describe than those of similar paradoxes because "the causal effect of BMi" is an ill-defined concept. 22, 23 even in the absence of confounding and other biases, it is unclear what causal effect, if any, is estimated when BMi is the exposure. for the same reason, conditioning on diabetes after baseline does not guarantee that the estimates can be interpreted as the direct effects of BMi on mortality, ie, effects not mediated through diabetes. (if the effect of BMi were well defined, one would still need to condition on all shared causes of diabetes and mortality [eg, genetic and lifestyle factors] 24, 25 , which is generally impossible, for an unbiased estimation of direct effects.)
Leaving aside causal inference considerations, suppose the goal is to estimate the association between baseline BMi (say, at age 30) and mortality. the paradox resolves itself by simply not conditioning the analysis on post-baseline disease. Studies restricted to patients with prevalent disease are conditioned on post-baseline disease by design and thus are not appropriate for estimating the association between baseline BMi and mortality. one can attempt to reconstruct this association using external data and strong statistical assumptions, 9 but a safer method is to refrain from conducting analyses restricted to patients with prevalent disease.
in summary, the inverse association observed between BMi and mortality among patients with diabetes, and perhaps other chronic diseases, might be qualitatively explained by selection bias because of stratification on a variable affected by the exposure. We hope that our findings encourage and facilitate future quantitative assessments of the paradox. At the very least, our work illustrates how being explicit about the causal question of interest helps clarify and interpret observations that may seem paradoxical at first sight.
